Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations.
Canale M, Petracci E, Cravero P, Mariotti M, Minuti G, Metro G, Ludovini V, Baglivo S, Puccetti M, Dubini A, Martinelli G, Delmonte A, Crinò L, Ulivi P. Canale M, et al. Among authors: metro g. Transl Oncol. 2022 Sep;23:101471. doi: 10.1016/j.tranon.2022.101471. Epub 2022 Jun 29. Transl Oncol. 2022. PMID: 35779323 Free PMC article.
Perspectives on salvage therapy for non-small-cell lung cancer.
Cappuzzo F, Finocchiaro G, Trisolini R, Toschi L, Bartolini S, Metro G, Crinò L. Cappuzzo F, et al. Among authors: metro g. Oncology (Williston Park). 2005 Jul;19(8):989-95; discussion 995-6, 999, 1003-4, passim. Oncology (Williston Park). 2005. PMID: 16131043 Review.
Clinical experience with gefitinib: an update.
Cappuzzo F, Finocchiaro G, Metro G, Bartolini S, Magrini E, Cancellieri A, Trisolini R, Castaldini L, Tallini G, Crino L. Cappuzzo F, et al. Among authors: metro g. Crit Rev Oncol Hematol. 2006 Apr;58(1):31-45. doi: 10.1016/j.critrevonc.2005.08.008. Epub 2006 Mar 13. Crit Rev Oncol Hematol. 2006. PMID: 16531062 Review.
Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib.
Cappuzzo F, Toschi L, Tallini G, Ceresoli GL, Domenichini I, Bartolini S, Finocchiaro G, Magrini E, Metro G, Cancellieri A, Trisolini R, Crino L, Bunn PA Jr, Santoro A, Franklin WA, Varella-Garcia M, Hirsch FR. Cappuzzo F, et al. Among authors: metro g. Ann Oncol. 2006 Jul;17(7):1120-7. doi: 10.1093/annonc/mdl077. Epub 2006 Apr 6. Ann Oncol. 2006. PMID: 16600976 Free article.
Treatment of advanced non-small cell lung cancer.
De Petris L, Crinò L, Scagliotti GV, Gridelli C, Galetta D, Metro G, Novello S, Maione P, Colucci G, de Marinis F. De Petris L, et al. Among authors: metro g. Ann Oncol. 2006 Mar;17 Suppl 2:ii36-41. doi: 10.1093/annonc/mdj919. Ann Oncol. 2006. PMID: 16608979 Free article. Review.
Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation.
Metro G, Chiari R, Mare M, Giannarelli D, Tofanetti FR, Minotti V, Ferraldeschi M, Giuffrida D, Marcomigni L, Bennati C, Fischer MJ, Meacci M, Bellavita R, Pistola L, Ludovini V, Crinò L. Metro G, et al. Cancer Chemother Pharmacol. 2011 Dec;68(6):1405-12. doi: 10.1007/s00280-011-1632-x. Epub 2011 Apr 6. Cancer Chemother Pharmacol. 2011. PMID: 21468755
184 results